Dr Boris Rodenko

  • Affiliate Researcher (Institute of Infection Immunity & Inflammation)

email: Boris.Rodenko@glasgow.ac.uk

RB623 Level B6, Iii - Gbrc, 120 University Place, Glasgow G12 8TA

Publications

List by: Type | Date

Jump to: 2020 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2007
Number of items: 14.

2020

Burge, R. J., Damianou, A., Wilkinson, A. J., Rodenko, B. and Mottram, J. C. (2020) Leishmania differentiation requires ubiquitin conjugation mediated by a UBC2-UEV1 E2 complex. PLoS Pathogens, 16(10), e1008784. (doi: 10.1371/journal.ppat.1008784) (PMID:33108402) (PMCID:PMC7647121)

Damianou, A., Burge, R. J., Catta-Preta, C. M.C., Geoghegan, V., Nievas, Y. R., Newling, K., Brown, E., Burchmore, R. , Rodenko, B. and Mottram, J. C. (2020) Essential roles for deubiquitination in Leishmania life cycle progression. PLoS Pathogens, 16(6), e1008455. (doi: 10.1371/journal.ppat.1008455) (PMID:32544189) (PMCID:PMC7319358)

2015

Rodenko, B., Wanner, M., Alkhaldi, A., Ebiloma, G., Barnes, R., Kaiser, M., Brun, R., McCulloch, R. , Koomen, G.-J. and De Koning, H. P. (2015) Targeting the parasite's DNA with methyltriazenyl purine analogs Is a safe, selective, and efficacious antitrypanosomal strategy. Antimicrobial Agents and Chemotherapy, 59(11), pp. 6708-6716. (doi: 10.1128/aac.00596-15) (PMID:26282430) (PMCID:PMC4604408)

2014

Hoppes, R. et al. (2014) Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes. Journal of Immunology, 193(10), pp. 4803-4813. (doi: 10.4049/jimmunol.1400800) (PMID:25311806) (PMCID:PMC4226423)

2013

Desmet, C.J. et al. (2013) Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America, 110(13), pp. 5139-5144. (doi: 10.1073/pnas.1222085110)

Rodenko, B. and De Koning, H. (2013) Rational selection of anti-microbial drug targets: unique or conserved? In: Jäger, T., Koch, O. and Flohé, L. (eds.) Trypanosomatid Diseases: Molecular Routes to Drug Discovery. Series: Drug discovery in infectious diseases (4). Wiley-Blackwell: Weinheim, pp. 279-296. ISBN 9783527332557 (doi:10.1002/9783527670383.ch15)

2012

Amore, A., Wals, K., Koekoek, E., Hoppes, R., Toebes, M., Schumacher, T.N.M., Rodenko, B. and Ovaa, H. (2012) Development of a hypersensitive periodate-cleavable amino acid that is methionine- and disulfide-compatible and its application in MHC exchange reagents for T cell Characterisation. ChemBioChem, 14(1), pp. 123-131. (doi: 10.1002/cbic.201200540)

de Jong, A., Merkx, R., Berlin, I., Rodenko, B., Wijdeven, R.H.M., El Atmioui, D., Yalçin, Z., Robson, C.N., Neefjes, J.J. and Ovaa, H. (2012) Ubiquitin-based probes prepared by total synthesis to profile the activity of deubiquitinating enzymes. ChemBioChem, 13(15), pp. 2251-2258. (doi: 10.1002/cbic.201200497)

Jong, A., Schuurman, K.G., Rodenko, B., Ovaa, H. and Berkers, C.R. (2012) Fluorescence-based proteasome activity profiling. Methods in Molecular Biology, 803, pp. 183-204. (doi: 10.1007/978-1-61779-364-6_13)

Natto, M.J., Savioli, F., Quashie, N.B., Dardonville, C., Rodenko, B. and De Koning, H.P. (2012) Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis. Journal of Antimicrobial Chemotherapy, 67(4), pp. 933-943. (doi: 10.1093/jac/dkr572)

2011

Rodenko, B., Al-Salabi, M.I., Teka, I.A., Ho, W., El-Sabbagh, N., Ali, J.A.M., Ibrahim, H.M.S., Wanner, M.J., Koomen, G.-J. and De Koning, H.P. (2011) Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity. ACS Medicinal Chemistry Letters, 2(12), pp. 901-906. (doi: 10.1021/ml200160k)

2009

Celie, P.H.N., Toebes, M., Rodenko, B., Ovaa, H., Perrakis, A. and Schumacher, T.N.M. (2009) UV-induced ligand exchange in MHC class I protein crystals. Journal of the American Chemical Society, 131(34), pp. 12298-12304. (doi: 10.1021/ja9037559)

Rodenko, B., Toebes, M., Celie, P.H.N., Perrakis, A., Schumacher, T.N.M. and Ovaa, H. (2009) Class I major histocompatibility complexes loaded by a periodate trigger. Journal of the American Chemical Society, 131(34), pp. 12305-12313. (doi: 10.1021/ja9037565)

2007

Rodenko, B., van der Burg, A.M., Wanner, M.J., Kaiser, M., Brun, R., Gould, M., de Koning, H.P. and Koomen, G.-J. (2007) 2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities. Antimicrobial Agents and Chemotherapy, 51(11), pp. 3796-3802.

This list was generated on Sat Oct 16 13:49:34 2021 BST.
Number of items: 14.

Articles

Burge, R. J., Damianou, A., Wilkinson, A. J., Rodenko, B. and Mottram, J. C. (2020) Leishmania differentiation requires ubiquitin conjugation mediated by a UBC2-UEV1 E2 complex. PLoS Pathogens, 16(10), e1008784. (doi: 10.1371/journal.ppat.1008784) (PMID:33108402) (PMCID:PMC7647121)

Damianou, A., Burge, R. J., Catta-Preta, C. M.C., Geoghegan, V., Nievas, Y. R., Newling, K., Brown, E., Burchmore, R. , Rodenko, B. and Mottram, J. C. (2020) Essential roles for deubiquitination in Leishmania life cycle progression. PLoS Pathogens, 16(6), e1008455. (doi: 10.1371/journal.ppat.1008455) (PMID:32544189) (PMCID:PMC7319358)

Rodenko, B., Wanner, M., Alkhaldi, A., Ebiloma, G., Barnes, R., Kaiser, M., Brun, R., McCulloch, R. , Koomen, G.-J. and De Koning, H. P. (2015) Targeting the parasite's DNA with methyltriazenyl purine analogs Is a safe, selective, and efficacious antitrypanosomal strategy. Antimicrobial Agents and Chemotherapy, 59(11), pp. 6708-6716. (doi: 10.1128/aac.00596-15) (PMID:26282430) (PMCID:PMC4604408)

Hoppes, R. et al. (2014) Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes. Journal of Immunology, 193(10), pp. 4803-4813. (doi: 10.4049/jimmunol.1400800) (PMID:25311806) (PMCID:PMC4226423)

Desmet, C.J. et al. (2013) Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America, 110(13), pp. 5139-5144. (doi: 10.1073/pnas.1222085110)

Amore, A., Wals, K., Koekoek, E., Hoppes, R., Toebes, M., Schumacher, T.N.M., Rodenko, B. and Ovaa, H. (2012) Development of a hypersensitive periodate-cleavable amino acid that is methionine- and disulfide-compatible and its application in MHC exchange reagents for T cell Characterisation. ChemBioChem, 14(1), pp. 123-131. (doi: 10.1002/cbic.201200540)

de Jong, A., Merkx, R., Berlin, I., Rodenko, B., Wijdeven, R.H.M., El Atmioui, D., Yalçin, Z., Robson, C.N., Neefjes, J.J. and Ovaa, H. (2012) Ubiquitin-based probes prepared by total synthesis to profile the activity of deubiquitinating enzymes. ChemBioChem, 13(15), pp. 2251-2258. (doi: 10.1002/cbic.201200497)

Jong, A., Schuurman, K.G., Rodenko, B., Ovaa, H. and Berkers, C.R. (2012) Fluorescence-based proteasome activity profiling. Methods in Molecular Biology, 803, pp. 183-204. (doi: 10.1007/978-1-61779-364-6_13)

Natto, M.J., Savioli, F., Quashie, N.B., Dardonville, C., Rodenko, B. and De Koning, H.P. (2012) Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis. Journal of Antimicrobial Chemotherapy, 67(4), pp. 933-943. (doi: 10.1093/jac/dkr572)

Rodenko, B., Al-Salabi, M.I., Teka, I.A., Ho, W., El-Sabbagh, N., Ali, J.A.M., Ibrahim, H.M.S., Wanner, M.J., Koomen, G.-J. and De Koning, H.P. (2011) Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity. ACS Medicinal Chemistry Letters, 2(12), pp. 901-906. (doi: 10.1021/ml200160k)

Celie, P.H.N., Toebes, M., Rodenko, B., Ovaa, H., Perrakis, A. and Schumacher, T.N.M. (2009) UV-induced ligand exchange in MHC class I protein crystals. Journal of the American Chemical Society, 131(34), pp. 12298-12304. (doi: 10.1021/ja9037559)

Rodenko, B., Toebes, M., Celie, P.H.N., Perrakis, A., Schumacher, T.N.M. and Ovaa, H. (2009) Class I major histocompatibility complexes loaded by a periodate trigger. Journal of the American Chemical Society, 131(34), pp. 12305-12313. (doi: 10.1021/ja9037565)

Rodenko, B., van der Burg, A.M., Wanner, M.J., Kaiser, M., Brun, R., Gould, M., de Koning, H.P. and Koomen, G.-J. (2007) 2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities. Antimicrobial Agents and Chemotherapy, 51(11), pp. 3796-3802.

Book Sections

Rodenko, B. and De Koning, H. (2013) Rational selection of anti-microbial drug targets: unique or conserved? In: Jäger, T., Koch, O. and Flohé, L. (eds.) Trypanosomatid Diseases: Molecular Routes to Drug Discovery. Series: Drug discovery in infectious diseases (4). Wiley-Blackwell: Weinheim, pp. 279-296. ISBN 9783527332557 (doi:10.1002/9783527670383.ch15)

This list was generated on Sat Oct 16 13:49:34 2021 BST.